STON2 and ovarian cancer: Furthermore, the results of the statistical analysis revealed a significant relationship between STON2 expression and clinicopathological characteristics of ovarian cancer (Table 2), and a Spearman’s correlation analysis verified that high STON2 expression was correlated with the following characteristics: intraperitoneal metastasis (p = 0.011), intestinal metastasis (p = 0.003), intraperitoneal recurrence (p = 0.006), ascites containing tumor cells (p = 0.016), and CA153 level (p = 0.041).